TIDMAMS
RNS Number : 1032C
Advanced Medical Solutions Grp PLC
10 April 2017
10 April 2017
Advanced Medical Solutions Group plc
("AMS", the "Company" or the "Group")
Director/PDMR and PCA Shareholding
Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), a
leading developer and manufacturer of advanced products for the
global surgical and advanced wound care markets, announces that the
Board, following a recommendation from the Remuneration Committee,
has granted new share options to the following Directors and PDMRs
under the Advanced Medical Solutions Long Term Incentive Plan (the
'LTIP') on 6 April 2017. The vesting period of these options is
subject to certain performance criteria over a three year
period.
Director/PDMR Options prior Options granted Resultant
to grant holding
================== ============== ================ ==========
Chris Meredith
Chief Executive
Officer 968,436 109,571 1,078,007
================== ============== ================ ==========
Mary Tavener
Chief Financial
Officer 591,199 84,762 675,961
================== ============== ================ ==========
Simon Coates
PDMR 91,864 17,891 109,755
================== ============== ================ ==========
Rose Guang
PDMR 138,011 24,067 162,078
================== ============== ================ ==========
Eddie Johnson
PDMR 120,364 23,775 144,139
================== ============== ================ ==========
Pieter van
Hoof
PDMR 121,505 23,428 144,933
================== ============== ================ ==========
Becky Walmsley
PDMR 50,000 23,082 73,082
================== ============== ================ ==========
Jeff Willis
PDMR 132,044 40,550 172,594
================== ============== ================ ==========
Advanced Medical Solutions Group plc also announces that on 6
April 2017, the Board, following a recommendation from the
Remuneration Committee, granted new share options to the following
Directors under the Advanced Medical Solutions Deferred Annual
Bonus Plan (the '2014 DAB').
This award is in respect of the part of their bonus that the
Directors and PDMRs are compulsorily required to defer for the 2016
financial year. These options vest at the end of three years.
Director/PDMR Options prior Options granted Resultant
to grant holding
================== ============== ================ ==========
Chris Meredith
Chief Executive
Officer 82,218 23,369 105,587
================== ============== ================ ==========
Mary Tavener
Chief Financial
Officer 57,870 15,065 72,935
================== ============== ================ ==========
Simon Coates
PDMR 4,438 3,306 7,744
================== ============== ================ ==========
Rose Guang
PDMR 12,586 4,612 17,198
================== ============== ================ ==========
Eddie Johnson
PDMR 14,803 4,556 19,359
================== ============== ================ ==========
Pieter van
Hoof
PDMR 13,490 4,329 17,819
================== ============== ================ ==========
Becky Walmsley
PDMR 1,067 4,114 5,181
================== ============== ================ ==========
Jeff Willis
PDMR 17,996 5,535 23,531
================== ============== ================ ==========
The notification below, made in accordance with the requirements
of the EU Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them
1. Details of the person discharging managerial
responsibilities/person closely associated
--- ---------------------------------------------------------------
a) Name: Chris Meredith
--- ---------------------------------------------------------------
2. Reason for the notification
--- ---------------------------------------------------------------
a) Position/status: Director/PDMR
--- ---------------------------------------------------------------
b) Initial notification/Amendment: Initial
Notification
--- ---------------------------------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- ---------------------------------------------------------------
a) Name: Advanced Medical Solutions Group
plc
--- ---------------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
--- ---------------------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- ---------------------------------------------------------------
a) Description of the financial instrument,
type of instrument: Ordinary Shares of
5p
Identification code: GB0004536594
--- ---------------------------------------------------------------
b) Nature of the transactions:
* Grant of 109,571 options under the Advanced Medical
Solutions Long Term Incentive Plan on 6 April 2017
* Grant of 23,369 options under the Advanced Medical
Solutions Deferred Annual Bonus Plan on 6 April 2017
--- ---------------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
--------- ----------
n/a n/a
--------- ----------
--- ---------------------------------------------------------------
d) Aggregated information: (Relates to those
shares sold only)
Aggregated volume: n/a
Aggregated price: n/a
--- ---------------------------------------------------------------
e) Date of the transaction: 06/04/2017
--- ---------------------------------------------------------------
f) Place of the transaction: London Stock
Exchange, AIM Market (XLON)
--- ---------------------------------------------------------------
1. Details of the person discharging managerial
responsibilities/person closely associated
--- ---------------------------------------------------------------
a) Name: Mary Tavener
--- ---------------------------------------------------------------
2. Reason for the notification
--- ---------------------------------------------------------------
a) Position/status: Director/PDMR
--- ---------------------------------------------------------------
b) Initial notification/Amendment: Initial
Notification
--- ---------------------------------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- ---------------------------------------------------------------
a) Name: Advanced Medical Solutions Group
plc
--- ---------------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
--- ---------------------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- ---------------------------------------------------------------
a) Description of the financial instrument,
type of instrument: Ordinary Shares of
5p
Identification code: GB0004536594
--- ---------------------------------------------------------------
b) Nature of the transactions:
* Grant of 84,762 options under the Advanced Medical
Solutions Long Term Incentive Plan on 6 April 2017
* Grant of 15,065 options under the Advanced Medical
Solutions Deferred Annual Bonus Plan on 6 April 2017
--- ---------------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
--------- ----------
n/a n/a
--------- ----------
--- ---------------------------------------------------------------
d) Aggregated information: (Relates to those
shares sold only)
Aggregated volume: n/a
Aggregated price: n/a
--- ---------------------------------------------------------------
e) Date of the transaction: 06/04/2017
--- ---------------------------------------------------------------
f) Place of the transaction: London Stock
Exchange, AIM Market (XLON)
--- ---------------------------------------------------------------
1. Details of the person discharging managerial
responsibilities/person closely associated
--- ---------------------------------------------------------------
a) Name: Simon Coates
--- ---------------------------------------------------------------
2. Reason for the notification
--- ---------------------------------------------------------------
a) Position/status: Director/PDMR
--- ---------------------------------------------------------------
b) Initial notification/Amendment: Initial
Notification
--- ---------------------------------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- ---------------------------------------------------------------
a) Name: Advanced Medical Solutions Group
plc
--- ---------------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
--- ---------------------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- ---------------------------------------------------------------
a) Description of the financial instrument,
type of instrument: Ordinary Shares of
5p
Identification code: GB0004536594
--- ---------------------------------------------------------------
b) Nature of the transactions:
* Grant of 17,891 options under the Advanced Medical
Solutions Long Term Incentive Plan on 6 April 2017
* Grant of 3,306 options under the Advanced Medical
Solutions Deferred Annual Bonus Plan on 6 April 2017
--- ---------------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
--------- ----------
n/a n/a
--------- ----------
--- ---------------------------------------------------------------
d) Aggregated information: (Relates to those
shares sold only)
Aggregated volume: n/a
Aggregated price: n/a
--- ---------------------------------------------------------------
e) Date of the transaction: 06/04/2017
--- ---------------------------------------------------------------
f) Place of the transaction: London Stock
Exchange, AIM Market (XLON)
--- ---------------------------------------------------------------
1. Details of the person discharging managerial
responsibilities/person closely associated
--- ---------------------------------------------------------------
a) Name: Rose Guang
--- ---------------------------------------------------------------
2. Reason for the notification
--- ---------------------------------------------------------------
a) Position/status: Director/PDMR
--- ---------------------------------------------------------------
b) Initial notification/Amendment: Initial
Notification
--- ---------------------------------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- ---------------------------------------------------------------
a) Name: Advanced Medical Solutions Group
plc
--- ---------------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
--- ---------------------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- ---------------------------------------------------------------
a) Description of the financial instrument,
type of instrument: Ordinary Shares of
5p
Identification code: GB0004536594
--- ---------------------------------------------------------------
b) Nature of the transactions:
* Grant of 24,067 options under the Advanced Medical
Solutions Long Term Incentive Plan on 6 April 2017
* Grant of 4,612 options under the Advanced Medical
Solutions Deferred Annual Bonus Plan on 6 April 2017
--- ---------------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
--------- ----------
n/a n/a
--------- ----------
--- ---------------------------------------------------------------
d) Aggregated information: (Relates to those
shares sold only)
Aggregated volume: n/a
Aggregated price: n/a
--- ---------------------------------------------------------------
e) Date of the transaction: 06/04/2017
--- ---------------------------------------------------------------
f) Place of the transaction: London Stock
Exchange, AIM Market (XLON)
--- ---------------------------------------------------------------
1. Details of the person discharging managerial
responsibilities/person closely associated
--- ---------------------------------------------------------------
a) Name: Eddie Johnson
--- ---------------------------------------------------------------
2. Reason for the notification
--- ---------------------------------------------------------------
a) Position/status: Director/PDMR
--- ---------------------------------------------------------------
b) Initial notification/Amendment: Initial
Notification
--- ---------------------------------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- ---------------------------------------------------------------
a) Name: Advanced Medical Solutions Group
plc
--- ---------------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
--- ---------------------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- ---------------------------------------------------------------
a) Description of the financial instrument,
type of instrument: Ordinary Shares of
5p
Identification code: GB0004536594
--- ---------------------------------------------------------------
b) Nature of the transactions:
* Grant of 23,775 options under the Advanced Medical
Solutions Long Term Incentive Plan on 6 April 2017
* Grant of 4,556 options under the Advanced Medical
Solutions Deferred Annual Bonus Plan on 6 April 2017
--- ---------------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
--------- ----------
n/a n/a
--------- ----------
--- ---------------------------------------------------------------
d) Aggregated information: (Relates to those
shares sold only)
Aggregated volume: n/a
Aggregated price: n/a
--- ---------------------------------------------------------------
e) Date of the transaction: 06/04/2017
--- ---------------------------------------------------------------
f) Place of the transaction: London Stock
Exchange, AIM Market (XLON)
--- ---------------------------------------------------------------
1. Details of the person discharging managerial
responsibilities/person closely associated
--- ---------------------------------------------------------------
a) Name: Pieter van Hoof
--- ---------------------------------------------------------------
2. Reason for the notification
--- ---------------------------------------------------------------
a) Position/status: Director/PDMR
--- ---------------------------------------------------------------
b) Initial notification/Amendment: Initial
Notification
--- ---------------------------------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- ---------------------------------------------------------------
a) Name: Advanced Medical Solutions Group
plc
--- ---------------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
--- ---------------------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- ---------------------------------------------------------------
a) Description of the financial instrument,
type of instrument: Ordinary Shares of
5p
Identification code: GB0004536594
--- ---------------------------------------------------------------
b) Nature of the transactions:
* Grant of 23,428 options under the Advanced Medical
Solutions Long Term Incentive Plan on 6 April 2017
* Grant of 4,329 options under the Advanced Medical
Solutions Deferred Annual Bonus Plan on 6 April 2017
--- ---------------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
--------- ----------
n/a n/a
--------- ----------
--- ---------------------------------------------------------------
d) Aggregated information: (Relates to those
shares sold only)
Aggregated volume: n/a
Aggregated price: n/a
--- ---------------------------------------------------------------
e) Date of the transaction: 06/04/2017
--- ---------------------------------------------------------------
f) Place of the transaction: London Stock
Exchange, AIM Market (XLON)
--- ---------------------------------------------------------------
1. Details of the person discharging managerial
responsibilities/person closely associated
--- ---------------------------------------------------------------
a) Name: Becky Walmsley
--- ---------------------------------------------------------------
2. Reason for the notification
--- ---------------------------------------------------------------
a) Position/status: Director/PDMR
--- ---------------------------------------------------------------
b) Initial notification/Amendment: Initial
Notification
--- ---------------------------------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- ---------------------------------------------------------------
a) Name: Advanced Medical Solutions Group
plc
--- ---------------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
--- ---------------------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- ---------------------------------------------------------------
a) Description of the financial instrument,
type of instrument: Ordinary Shares of
5p
Identification code: GB0004536594
--- ---------------------------------------------------------------
b) Nature of the transactions:
* Grant of 23,082 options under the Advanced Medical
Solutions Long Term Incentive Plan on 6 April 2017
* Grant of 4,114 options under the Advanced Medical
Solutions Deferred Annual Bonus Plan on 6 April 2017
--- ---------------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
--------- ----------
n/a n/a
--------- ----------
--- ---------------------------------------------------------------
d) Aggregated information: (Relates to those
shares sold only)
Aggregated volume: n/a
Aggregated price: n/a
--- ---------------------------------------------------------------
e) Date of the transaction: 06/04/2017
--- ---------------------------------------------------------------
f) Place of the transaction: London Stock
Exchange, AIM Market (XLON)
--- ---------------------------------------------------------------
1. Details of the person discharging managerial
responsibilities/person closely associated
--- ---------------------------------------------------------------
a) Name: Jeff Willis
--- ---------------------------------------------------------------
2. Reason for the notification
--- ---------------------------------------------------------------
a) Position/status: Director/PDMR
--- ---------------------------------------------------------------
b) Initial notification/Amendment: Initial
Notification
--- ---------------------------------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- ---------------------------------------------------------------
a) Name: Advanced Medical Solutions Group
plc
--- ---------------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
--- ---------------------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- ---------------------------------------------------------------
a) Description of the financial instrument,
type of instrument: Ordinary Shares of
5p
Identification code: GB0004536594
--- ---------------------------------------------------------------
b) Nature of the transactions:
* Grant of 40,550 options under the Advanced Medical
Solutions Long Term Incentive Plan on 6 April 2017
* Grant of 5,535 options under the Advanced Medical
Solutions Deferred Annual Bonus Plan on 6 April 2017
--- ---------------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
--------- ----------
n/a n/a
--------- ----------
--- ---------------------------------------------------------------
d) Aggregated information: (Relates to those
shares sold only)
Aggregated volume: n/a
Aggregated price: n/a
--- ---------------------------------------------------------------
e) Date of the transaction: 06/04/2017
--- ---------------------------------------------------------------
f) Place of the transaction: London Stock
Exchange, AIM Market (XLON)
--- ---------------------------------------------------------------
- End -
For further information, please visit www.admedsol.com or
contact:
Advanced Medical Solutions Group Tel: +44 (0)
plc 1606 545508
Chris Meredith, Chief Executive
Officer
Mary Tavener, Chief Financial
Officer
Consilium Strategic Communications Tel: +44 (0)
20 3709 5700
Mary-Jane Elliott / Jonathan AMS@consilium-comms.com
Birt / Matthew Neal / Hendrik
Thys
Investec Bank PLC (NOMAD & Broker) Tel: +44 (0)
20 7597 5970
Daniel Adams / Patrick Robb
About Advanced Medical Solutions Group plc - see
www.admedsol.com
AMS is a world-leading independent developer and manufacturer of
innovative and technologically advanced products for the global
surgical and advanced wound care markets, focused on quality
outcomes for patients and value for payors. AMS has a wide range of
wound care products that include silver alginates, alginates,
foams, tissue adhesives, sutures and haemostats, which it sells
under white label as well as its own brand ActivHeal(R) , and
surgical tissue adhesives, sutures and haemostats, which markets
under its own brands; LiquiBand(R) and RESORBA(R) .
AMS's products, manufactured out of two sites in the UK, one in
the Netherlands, two in Germany and one in the Czech Republic, are
sold in more than 70 countries via a network of multinational or
regional partners and distributors, as well as via AMS's own direct
sales forces in the UK, Germany, the Czech Republic and Russia.
Established in 1991, the Company has 600 employees. For more
information, please see www.admedsol.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHBSGDSXDBBGRG
(END) Dow Jones Newswires
April 10, 2017 10:26 ET (14:26 GMT)
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Feb 2024 to Mar 2024
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Mar 2023 to Mar 2024